A 10-year-long study called the PanCancer Atlas is releasing a trove of genetic data in an effort to help doctors treat a wide variety of cancers more precisely.
The history: Over the past decade, 150 researchers from the US and around the world painstakingly analyzed DNA, RNA, and proteins from tumor samples of more than 11,000 patients with 33 different types of cancer.
The findings: From that data, scientists have identified about 300 genes that drive tumor growth. They also found that just over half the tumors samples analyzed carry genetic mutations that could be targeted by therapies that are already on the market. These findings and others appear in 29 different papers today in the journal Cell.
Why it matters: Researchers say the insights gleaned can be used to tailor more personalized treatments for cancer patients. “This analysis provides cancer researchers with unprecedented understanding of how, where, and why tumors arise in humans, enabling better-informed clinical trials and future treatments,” says Francis Collins, director of the US National Institutes of Health, which funded the project.
Biotechnology and health
Scientists are finding signals of long covid in blood. They could lead to new treatments.
Faults in a certain part of the immune system might be at the root of some long covid cases, new research suggests.
Gene editing had a banner year in 2023
This year, gene editing finally started living up to its potential
The first gene-editing treatment: 10 Breakthrough Technologies 2024
Sickle-cell disease is the first illness to be beaten by CRISPR, but the new treatment comes with an expected price tag of $2 to $3 million.
This baby with a head camera helped teach an AI how kids learn language
A neural network trained on the experiences of a single young child managed to learn one of the core components of language: how to match words to the objects they represent.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.